About: Anemia and Transfusions in Patients Undergoing Surgery for Cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Anemia and Transfusions in Patients Undergoing Surgery for Cancer Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Anemia and Transfusions in Patients Undergoing Surgery for Cancer
Creator	Jabbour, Nicolas Weber, Randal Ii, Robert
Source	PMC
abstract	Preoperative, operative, and postoperative factors may all contribute to high rates of anemia in patients undergoing surgery for cancer. Allogeneic blood transfusion is associated with both infectious risks and noninfectious risks such as human errors, hemolytic reactions, transfusion-related acute lung injury, transfusion-associated graft-versus-host disease, and transfusion-related immune modulation. Blood transfusion may also be associated with increased risk of cancer recurrence. Blood-conservation measures such as preoperative autologous donation, acute normovolemic hemodilution, perioperative blood salvage, recombinant human erythropoietin (epoetin alfa), electrosurgical dissection, and minimally invasive surgical procedures may reduce the need for allogeneic blood transfusion in elective surgery. This review summarizes published evidence of the consequences of anemia and blood transfusion, the effects of blood storage, the infectious and noninfectious risks of blood transfusion, and the role of blood-conservation strategies for cancer patients who undergo surgery. The optimal blood-management strategy remains to be defined by additional clinical studies. Until that evidence becomes available, the clinical utility of blood conservation should be assessed for each patient individually as a component of preoperative planning in surgical oncology.
has issue date	2007-10-18(xsd:dateTime)
bibo:doi	10.1245/s10434-007-9502-9
bibo:pmid	17943390
has license	no-cc
sha1sum (hex)	b81d7821ef4e43240ee46a93e682080dc5653ce3
schema:url	https://doi.org/10.1245/s10434-007-9502-9
resource representing a document's title	Anemia and Transfusions in Patients Undergoing Surgery for Cancer
has PubMed Central identifier	PMC7101818
has PubMed identifier	17943390
schema:publication	Ann Surg Oncol
resource representing a document's body	covid:b81d7821ef4e43240ee46a93e682080dc5653ce3#body_text
is schema:about of	named entity 'assessed' named entity 'defined' named entity 'patient' named entity 'ADDITIONAL' named entity 'BLOOD' named entity 'NONINFECTIOUS' named entity 'ASSOCIATED' named entity 'MINIMALLY INVASIVE SURGICAL PROCEDURES' named entity 'CONSEQUENCES' named entity 'RECOMBINANT HUMAN ERYTHROPOIETIN' named entity 'ASSESSED' named entity 'DONATION' named entity 'AVAILABLE' named entity 'CONSERVATION' named entity 'BLOOD TRANSFUSION' named entity 'DISSECTION' named entity 'ERRORS' covid:arg/b81d7821ef4e43240ee46a93e682080dc5653ce3 named entity 'surgery' named entity 'patients' named entity 'risk' named entity 'blood transfusion' named entity 'The' named entity 'elective surgery' named entity 'anemia' named entity 'summarizes' named entity 'utility' named entity 'evidence' named entity 'anemia' named entity 'surgical oncology' named entity 'patients' named entity 'immune modulation' named entity 'anemia' named entity 'blood transfusion' named entity 'recombinant human erythropoietin' named entity 'clinical studies' named entity 'blood transfusion' named entity 'noninfectious' named entity 'allogeneic' named entity 'minimally invasive surgical procedures' named entity 'autologous donation' named entity 'blood transfusion' named entity 'epoetin alfa' named entity 'anemia' named entity '8.5' named entity 'blood transfusions' named entity 'asymptomatic' named entity 'clinical studies' named entity 'randomized study' named entity 'hepatectomy' named entity 'oxygen' named entity 'PAD' named entity 'blood transfusion' named entity 'quality of life' named entity 'tumor stage' named entity 'gastrectomy' named entity 'anemia' named entity 'poor nutrition' named entity 'hematocrit' named entity 'prognostic factor' named entity 'perioperative care' named entity 'dissection' named entity 'lung resection' named entity 'blood transfusion' named entity 'aprotinin' named entity 'anemia of chronic disease' named entity 'TRALI' named entity 'disease-free survival' named entity 'observational study' named entity 'anemia' named entity 'cellular components' named entity '15,000' named entity 'TNF-a' named entity 'oxygen' named entity 'T-lymphocytes' named entity 'Autologous blood' named entity 'Transfusions' named entity 'TRALI' named entity 'PAD'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software